- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
A UK health professional complained that the Ajovy website entry pop-up lacked the generic name and black triangle.…
Pulse ad for Trixeo linked COPD exacerbations and death with a “Take action with Trixeo” call-to-action, creating an…
PMCPA case AUTH/3728/1/23: complaint alleging promotion of Zeposia (ozanimod hydrochloride) against Bristol Myers Squibb. Outcome: no breach; matter…
Complaint alleged Roche funding wasn’t declared “from the outset” on patient organisation programme webpages/materials. Panel found complainant hadn’t…
An anonymous representative alleged pressure to promote Aldara off-licence and raised concerns about call-rate targets and a GP…
Novartis’ UK press release headline implied an overall survival benefit for Femara vs tamoxifen despite non-significant ITT results…
Allergan’s Botox monograph made comparative claims vs Dysport (and referenced Xeomin). Panel found several claims misleading/unsubstantiated and ruled…
A trust clinical director alleged a Pfizer rep was intimidating and applied inappropriate pressure when trying to access…
Cephalon’s internal congress feedback note described “clubbing” and late-night bars with HCPs and urged “lets make sure they…
A Protopic leavepiece themed around “a whole British summer” was ruled inconsistent with the SPC warning to minimise…
One real case. One key lesson. Every week — free.